股东权益报酬率(%) RoE | |
Novo Nor | 74.4 |
Neurocri | 16.5 |
Bio-Tech | 13.5 |
Freeline | 0 |
Atara Bi | 0 |
Autolus | 0 |
AVROBIO, | 0 |
头脑风暴细胞治疗 | 0 |
BioCryst | 0 |
bluebird | 0 |
Biondvax | 0 |
CASI制药公司 | 0 |
Compugen | 0 |
Coherus生 | 0 |
Cellecti | 0 |
Curis, I | 0 |
CRISPR T | 0 |
冠军肿瘤公司 | 0 |
CEL-SCI | 0 |
Denali T | 0 |
Eiger Bi | 0 |
Entera B | 0 |
ERYTECH | 0 |
Fate The | 0 |
基因技术有限公司 | 0 |
Halozyme | 0 |
Krystal | 0 |
aTyr制药公司 | 0 |
MeiraGTx | 0 |
Calyxt, | 0 |
Nanostri | 0 |
现金与约当现金比率(%) | |
Kura Onc | 96.6 |
Aprea Th | 95.5 |
AVROBIO, | 93.6 |
Dyadic I | 92.8 |
Entera B | 92.5 |
Tracon制药 | 90.4 |
Cardiff | 90.3 |
Genenta | 89.8 |
Organovo | 88.9 |
Ngm Biop | 88.7 |
Vincerx | 87.8 |
Leap The | 87.1 |
Immatics | 87.1 |
Eiger Bi | 86.1 |
InVivo T | 84.9 |
CRISPR T | 84.9 |
Fresh Tr | 84.2 |
Achilles | 83.6 |
Solid Bi | 83.5 |
Capricor | 83.5 |
aTyr制药公司 | 82.3 |
Denali T | 81.9 |
BioCryst | 81.2 |
9 Meters | 80.8 |
Argenx S | 80.5 |
Exscient | 77.9 |
Compugen | 77.7 |
Krystal | 76.6 |
Aceragen | 76.4 |
Genfit S | 75.5 |
Mustang | 75.4 |
营业毛利率(%) | |
Cellecti | 1946.5 |
Titan制药公 | 355.4 |
Bionomic | 122.5 |
Capricor | 100.0 |
Armata P | 100.0 |
Portage | 100.0 |
Sangamo | 100.0 |
CEL-SCI | 100.0 |
Immunoco | 99.8 |
Neurocri | 98.6 |
Pluri In | 97.7 |
Lexicon | 96.8 |
Argenx S | 96.2 |
Curis, I | 95.1 |
BioCryst | 94.7 |
Genfit S | 94.1 |
Krystal | 93.9 |
Organovo | 92.8 |
Eiger Bi | 92.7 |
Compugen | 91.7 |
Seagen I | 86.2 |
Vaxart, | 85.7 |
Liquidia | 80.0 |
Halozyme | 79.6 |
Moderna, | 76.9 |
Acorda T | 76.4 |
Coherus生 | 74.9 |
Ginkgo B | 74.8 |
Lineage | 74.7 |
Orchard | 74.2 |
Novavax, | 73.2 |
营业利益率(%) | |
Halozyme | 32.6 |
Qiagen N | 25.6 |
Bio-Tech | 23.8 |
Neurocri | 23.2 |
Novo Nor | 17.6 |
Abcam Pl | 15.5 |
Zura Bio | 0 |
头脑风暴细胞治疗 | 0 |
ProKidne | 0 |
9 Meters | 0 |
Biondvax | 0 |
Mustang | 0 |
AVROBIO, | 0 |
Quince T | 0 |
Genenta | 0 |
Gamida C | 0 |
Freeline | 0 |
Kura Onc | 0 |
Vincerx | 0 |
ARYA Sci | 0 |
Achilles | 0 |
InVivo T | 0 |
ERYTECH | 0 |
Edoc Acq | 0 |
Aprea Th | 0 |
ANI Phar | -2.1 |
冠军肿瘤公司 | -2.1 |
BioNTech | -2.2 |
Vericel | -5.3 |
Protalix | -16.0 |
Seagen I | -22.2 |
纯益率 / 净利率(%) | |
CEL-SCI | 6838.5 |
Halozyme | 33.4 |
Bio-Tech | 21.7 |
Krystal | 21.6 |
Qiagen N | 15.3 |
Neurocri | 15.0 |
Novo Nor | 13.7 |
Abcam Pl | 11.3 |
Edoc Acq | 0 |
头脑风暴细胞治疗 | 0 |
Biondvax | 0 |
ARYA Sci | 0 |
Aprea Th | 0 |
Gamida C | 0 |
Achilles | 0 |
AVROBIO, | 0 |
Genenta | 0 |
Mustang | 0 |
9 Meters | 0 |
Kura Onc | 0 |
InVivo T | 0 |
ProKidne | 0 |
ERYTECH | 0 |
Quince T | 0 |
Vincerx | 0 |
Zura Bio | 0 |
Freeline | 0 |
冠军肿瘤公司 | -2.9 |
Vericel | -4.5 |
BioNTech | -5.8 |
ANI Phar | -7.8 |
分红率(%) | |
Novo Nor | 7.045075 |
Bio-Tech | 0.32 |
Freeline | 0 |
Argenx S | 0 |
Atara Bi | 0 |
Autolus | 0 |
AVROBIO, | 0 |
头脑风暴细胞治疗 | 0 |
BioCryst | 0 |
bluebird | 0 |
Biondvax | 0 |
CASI制药公司 | 0 |
Compugen | 0 |
Coherus生 | 0 |
Cellecti | 0 |
Curis, I | 0 |
CRISPR T | 0 |
冠军肿瘤公司 | 0 |
CEL-SCI | 0 |
Denali T | 0 |
Eiger Bi | 0 |
Entera B | 0 |
ERYTECH | 0 |
Fate The | 0 |
基因技术有限公司 | 0 |
Halozyme | 0 |
Krystal | 0 |
aTyr制药公司 | 0 |
MeiraGTx | 0 |
Neurocri | 0 |
Nanostri | 0 |